RESEARCH REPORT
Netflix, Inc.
NFLX
$62.08
As of 2026-11-01
Research note — 2026-11-01. Educational analysis, not financial advice.
The one-line version
Netflix, Inc. trades near $62.08 on a trailing multiple of about 17.9x versus its own 5-year median near 25.8x, against contested Street targets and the usual concentration and execution risks. That's the tension. Everything below is the detail.
That's the tension. Everything below is the detail.
1. What you're paying
| Now | Its own 5-year median | Gap | |
|---|---|---|---|
| P/E (trailing) | ~17.9 | ~25.8 | -30% |
| P/E (forward) | ~16.5 | — | — |
| EPS (TTM) | 3.46 | — | — |
| Gross margin | 50.7% | — | — |
What that means in plain terms: the gap versus the company's own history is the growth or durability the market is already pricing. It is not automatically wrong — it is the bet.
Fair-value anchors on file:
- 5-year median P/E multiple: $89.13 — Applies the 5-year median multiple (25.8x) to trailing EPS.
- Street mean target: $84.76 — Average published analyst target.
- Street target midpoint: $91.50 — Midpoint of $57.00–$126.00 published range.
Street targets run from $57.00 to $126.00. A wide spread means the name is contested, not consensus.
2. What the bulls are counting on
- France Wants a 5.5-Cent-per-Gigabyte Tax on Netflix, Google and Meta
- 3 Unstoppable S&P 500 Stocks to transact in in November
- Jim Cramer flags Netflix's 'biggest problem,' and it isn't price
Sign up free to read the full analysis
Bull case, bear case, assumptions, and what to watch next.
3. What the bears see
- Netflix Slides to a 52-Week Low as Its Ad Business Runs “a Bit Behind” Its $3 Billion Target
- Apple Leads Packed Earnings Calendar As market participants Eye Tech, Pharma Results
- Down 33.3% This Year, Is Netflix the Best Value Stock to transact in in November?
Sign up free to read the full analysis
Bull case, bear case, assumptions, and what to watch next.
4. What would have to be true
For the stock to justify ~17.9x rather than its 5-year ~25.8x, roughly all of the following need to neutral:
- Growth or margin durability shows up in the next several reports, not just in narrative.
- Key revenue concentrations survive competitive and regulatory pressure.
- Execution on the current product or services cycle stays on schedule.
- The Street target range compresses as results clarify the contested assumptions.
Ask yourself honestly: how many of those would you bet on individually? Multiply your answers together.
Sign up free to read the full analysis
Bull case, bear case, assumptions, and what to watch next.
5. What to watch next
- Next earnings date: 2027-01-18
- Trailing and forward multiples versus the company's own history
- Segment growth rates in the next 10-Q / earnings release
- Material Form 4 and 13F changes
- Whether the Street high-to-low target spread narrows or widens
Sign up free to read the full analysis
Bull case, bear case, assumptions, and what to watch next.
6. What this note does not do
It doesn't tell you to buy or sell. It won't, ever.
You have the valuation in context, the strongest version of both cases, and the specific assumptions the current price depends on. What you do with that depends on your time horizon, your existing exposure, your risk tolerance, and what else you could do with the money — none of which we know.
If you want someone to tell you what to do, you want a licensed financial adviser, and that is a genuinely reasonable thing to want.
Educational and informational purposes only. Not investment advice and not a recommendation to buy or sell any security. GetStockReport is not a registered investment adviser. Figures are as of 2026-11-01 and go stale quickly — verify against primary sources before acting. All investments carry risk including loss of principal. Past performance does not guarantee future results.
8. Analyst ratings & targets
No recent activity
Analyst opinions change frequently. Past upgrades do not predict future returns.
9. Important news
Nov 6, 2026|IMAX (IMAX) CEO Defends Offering Premium Screens To A High Profile Streaming Release(Yahoo)
IMAX (NYSE:IMAX) CEO publicly addressed decisions by major theater chains to forgo showing a high profile Netflix film on IMAX screens. The chief executive said the company had offered IMAX auditoriums for the Netflix title while some exhibition partners held back. Management framed the episode as part of broader talks with studios and streaming platforms over how premium screens are allocated. The CEO's pushback on the Netflix IMAX release decision reflects wider shifts in premium screen...
Nov 6, 2026|Investors Heavily Search Netflix, Inc. (NFLX): Here is What You Need to Know(Yahoo)
Netflix (NFLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Nov 6, 2026|Netflix (NFLX) Stock Looks Cheap With 23% Upside To Fair Value(Yahoo)
Netflix has seen a sharp swing in sentiment, with the share price down 40.2% over the past year but still ahead 50.7% over three years. This puts fresh attention on whether the current market value lines up with the cash the business can realistically generate. With investors weighing headlines on growth, advertising and engagement, the central issue now is how much of Netflix's future cash flows are already embedded in the price. The 50.7% gain over the past three years means long term...
Nov 6, 2026|Disney struggles as Netflix pulls away: Time to buy the dip?(Yahoo)
Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Nov 6, 2026|Netflix's Loyal Subscribers Are Not Priced Correctly(SeekingAlpha)
Netflix is rated buy, trading at a five-year valuation low despite industry-leading customer loyalty and retention rates. Read more on NFLX stock here.
News headlines are reported as-is. Verify important claims with original sources.
10. Insider Form 4 activity
| Date | Executive | Action | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 14,018 | — |
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 25,930 | — |
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 14,440 | — |
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 6,979 | $435,070.86 |
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 12,908 | $804,684.72 |
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 7,189 | $448,162.26 |
| Nov 4, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 27,312 | $1.8M |
| Nov 3, 2026 | SARANDOS THEODORE A (Co-CEO) | Sell | 25,930 | $0 |
Form 4 filings are routine transactions. Scheduled sales (10b5-1 plans) are normal and not signals.
11. Institutional 13F holdings
| Fund | Shares | Position | Change |
|---|---|---|---|
| Vanguard Group | 347,536,451 | $32.6B | — |
| State Street | 180,129,582 | $12.9B | — |
| BlackRock | 11,607,551 | $7.8B | — |
| BlackRock Institutional Trust | 1,526,712 | $189.0M | — |
These are 45-day lagged filings (SEC requirement). Position changes happened in the past.
12. Earnings this week
No recent activity
Earnings dates are estimates and may shift. EPS estimates are consensus, not predictions.